American scientists from the La Jolla Institute of Immunology announced the discovery of the nucleocapsid structure of filoviruses, which include...
Vous n'êtes pas connecté
Scientists at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have made a surprising finding about how antibodies behave in COVID-19 infections. Their research shows that antibodies, which the body creates to fight off viruses, can sometimes have opposite effects. This means that some antibodies can either help block the virus […]
American scientists from the La Jolla Institute of Immunology announced the discovery of the nucleocapsid structure of filoviruses, which include...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful consideration when prescribing...
Source: Zim scientists claim major cancer discovery -Newsday Zimbabwe The scientists are working with the University of the Witswatersrand, in...
Officials with Hastings Prince Edward Public Health are advising people to make sure they are properly protected against respiratory viruses. Dr....
Scientists at the Cavendish Laboratory in Cambridge have created a new phase of matter, called a Bose glass, that challenges traditional understanding...
Scientists at the Cavendish Laboratory in Cambridge have created a new phase of matter, called a Bose glass, that challenges traditional understanding...
Scientists from Harvard have uncovered a surprising finding: nearly 1 in 5 people with high blood pressure may unknowingly be taking medications for...
Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the disease every year. So...